|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
3
|
Diao Y, Guo X, Jiang L, Wang G, Zhang C,
Wan J, Jin Y and Wu Z: miR-203, a tumor suppressor frequently
downregulated by promoter hypermethylation in rhabdomyosarcoma. J
Biol Chem. 289:529–539. 2014. View Article : Google Scholar :
|
|
4
|
Gong C, Qu S, Lv XB, Liu B, Tan W, Nie Y,
Su F, Liu Q, Yao H and Song E: BRMS1L suppresses breast cancer
metastasis by inducing epigenetic silence of FZD10. Nat Commun.
5:54062014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu K, Wang J, Song Y, Zhao S, Liu H, Tang
D, Pan B, Zhao H and Zhang Q: miRNA-24-3p promotes cell
proliferation and inhibits apoptosis in human breast cancer by
targeting p27Kip1. Oncol Rep. 34:995–1002.
2015.PubMed/NCBI
|
|
6
|
Cui L, Zhang X, Ye G, Zheng T, Song H,
Deng H, Xiao B, Xia T, Yu X, Le Y, et al: Gastric juice microRNAs
as potential biomarkers for the screening of gastric cancer.
Cancer. 119:1618–1626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
8
|
Tian XY, Zhang L, Sun LG and Li M:
Epigenetic regulation of miR-129-2 leads to overexpression of
PDGFRa and FoxP1 in glioma cells. Asian Pac J Cancer Prev.
16:6129–6133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao Y, Li X, Wang H, Wen R, He J and Tang
J: Epigenetic regulation of miR-129-2 and its effects on the
proliferation and invasion in lung cancer cells. J Cell Mol Med.
19:2172–2180. 2015.PubMed/NCBI
|
|
10
|
Yang Y, Huang JQ, Zhang X and Shen LF:
miR-129-2 functions as a tumor suppressor in glioma cells by
targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell
Biochem. 404:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Y, Huang C, Zhang L and Li J:
Epigenetic repression of miR-129-2 in cancer. Liver Int.
34:6462014. View Article : Google Scholar
|
|
12
|
Kang M, Li Y, Liu W, Wang R, Tang A, Hao
H, Liu Z and Ou H: miR-129-2 suppresses proliferation and migration
of esophageal carcinoma cells through downregulation of SOX4
expression. Int J Mol Med. 32:51–58. 2013.PubMed/NCBI
|
|
13
|
Lu CY, Lin KY, Tien MT, Wu CT, Uen YH and
Tseng TL: Frequent DNA methylation of miR-129-2 and its potential
clinical implication in hepatocellular carcinoma. Genes Chromosomes
Cancer. 52:636–643. 2013.PubMed/NCBI
|
|
14
|
Bedi U, Mishra VK, Wasilewski D, Scheel C
and Johnsen SA: Epigenetic plasticity: A central regulator of
epithelial-to-mesenchymal transition in cancer. Oncotarget.
5:2016–2029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen QW, Zhu XY, Li YY and Meng ZQ:
Epigenetic regulation and cancer (Review). Oncol Rep. 31:523–532.
2014.
|
|
16
|
Sang Y, Cheng C, Tang XF, Zhang MF and Lv
XB: Hypermethylation of TET1 promoter is a new diagnosic marker for
breast cancer metastasis. Asian Pac J Cancer Prev. 16:1197–1200.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong Y and Wang A: Aberrant DNA
methylation in hepatocellular carcinoma tumor suppression (Review).
Oncol Lett. 8:963–968. 2014.PubMed/NCBI
|
|
18
|
Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T,
Song E and Yu F: miR-124 suppresses multiple steps of breast cancer
metastasis by targeting a cohort of pro-metastatic genes in vitro.
Chin J Cancer. 30:821–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X,
Liu Y, He Y, Park EY, Zhang H, et al: MicroRNA 34c gene
downregulation via DNA methylation promotes self-renewal and
epithelial-mesenchymal transition in breast tumor-initiating cells.
J Biol Chem. 287:465–473. 2012. View Article : Google Scholar :
|
|
20
|
Li HP, Huang HY, Lai YR, Huang JX, Chang
KP, Hsueh C and Chang YS: Silencing of miRNA-148a by
hypermethylation activates the integrin-mediated signaling pathway
in nasopharyngeal carcinoma. Oncotarget. 5:7610–7624. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yim RL, Wong KY, Kwong YL, Loong F, Leung
CY, Chu R, Lam WW, Hui PK, Lai R and Chim CS: Methylation of
miR-155-3p in mantle cell lymphoma and other non-Hodgkin's
lymphomas. Oncotarget. 5:9770–9782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Q, Yang Z, Xia L, Nie Y, Wu K, Shi Y
and Fan D: Methylation of miR-129-5p CpG island modulates
multi-drug resistance in gastric cancer by targeting ABC
transporters. Oncotarget. 5:11552–11563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv XB, Wu W, Tang X, Wu Y, Zhu Y, Liu Y,
Cui X, Chu J, Hu P, Li J, et al: Regulation of SOX10 stability via
ubiquitination-mediated degradation by Fbxw7α modulates melanoma
cell migration. Oncotarget. 6:36370–36382. 2015.PubMed/NCBI
|
|
24
|
Lv XB, Zhang X, Deng L, Jiang L, Meng W,
Lu Z and Wang X: miR-92a mediates AZD6244 induced apoptosis and
G1-phase arrest of lymphoma cells by targeting Bim. Cell Biol Int.
38:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salilew-Wondim D, Hölker M, Rings F,
Phatsara C, Mohammadi-Sangcheshmeh A, Tholen E, Schellander K and
Tesfaye D: Depletion of BIRC6 leads to retarded bovine early
embryonic development and blastocyst formation in vitro. Reprod
Fertil Dev. 22:564–579. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Døssing KB, Binderup T, Kaczkowski B,
Jacobsen A, Rossing M, Winther O, Federspiel B, Knigge U, Kjær A
and Friis-Hansen L: Down-regulation of miR-129-5p and the let-7
family in neuro-endocrine tumors and metastases leads to
up-regulation of their targets Egr1, G3bp1, Hmga2 and Bach1. Genes
(Basel). 6:1–21. 2014.
|
|
27
|
Tan G, Cao X, Dai Q, Zhang B, Huang J,
Xiong S, Zhang Y, Chen W, Yang J and Li H: A novel role for
microRNA-129-5p in inhibiting ovarian cancer cell proliferation and
survival via direct suppression of transcriptional co-activators
YAP and TAZ. Oncotarget. 6:8676–8686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duan L, Hao X, Liu Z, Zhang Y and Zhang G:
miR-129-5p is down-regulated and involved in the growth, apoptosis
and migration of medullary thyroid carcinoma cells through
targeting RET. FEBS Lett. 588:1644–1651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li M, Tian L, Wang L, Yao H, Zhang J, Lu
J, Sun Y, Gao X, Xiao H and Liu M: Down-regulation of miR-129-5p
inhibits growth and induces apoptosis in laryngeal squamous cell
carcinoma by targeting APC. PLoS One. 8:e778292013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang ZM, Yang J, Shen XY, Zhang XY, Meng
FS, Xu JT, Zhang BF and Gao HJ: MicroRNA expression profile in
non-cancerous colonic tissue associated with lymph node metastasis
of colon cancer. J Dig Dis. 10:188–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu T, Weng S, Tang W, Xue R, Chen S, Cai
G, Cai Y, Shen X, Zhang S and Dong L: Overexpression of BIRC6 is a
predictor of prognosis for colorectal cancer. PLoS One.
10:e01252812015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luk SU, Xue H, Cheng H, Lin D, Gout PW,
Fazli L, Collins CC, Gleave ME and Wang Y: The BIRC6 gene as a
novel target for therapy of prostate cancer: Dual targeting of
inhibitors of apoptosis. Oncotarget. 5:6896–6908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang W, Xue R, Weng S, Wu J, Fang Y, Wang
Y, Ji L, Hu T, Liu T, Huang X, et al: BIRC6 promotes hepatocellular
carcinogenesis: Interaction of BIRC6 with p53 facilitating p53
degradation. Int J Cancer. 136:E475–E487. 2015. View Article : Google Scholar
|
